Acadia Pharmaceuticals reported 16.19 in PE Price to Earnings for its fiscal quarter ending in June of 2025.


Pe Change Date
Acadia Pharmaceuticals 16.19 4.11 Jun/2025
ALKERMES 13.78 1.23 Jun/2025
Biogen 12.41 0.17 Jun/2025
BioMarin Pharmaceutical 15.13 7.26 Jun/2025
Bristol-Myers Squibb 17.27 3.22 Jun/2025
Corcept Therapeutics 63.83 34.36 Jun/2025
Eisai 20.04 10.16 Dec/2024
Eli Lilly 37 7.55 Jun/2025
Incyte 14.77 134.3 Jun/2025
J&J 19.02 9.62 Jun/2025
Moderna 27.22 14.51 Jun/2023
Neurocrine Biosciences 42.61 5.9 Jun/2025
Pfizer 9.12 8.86 Jun/2025
Prothena 22.11 11.37 Mar/2022
PTC Therapeutics 6.47 0.7 Jun/2025
Sarepta Therapeutics 27.27 0 Jun/2025
Vertex Pharmaceuticals 27.81 3.5 Jun/2025